Skip to Content

Mephobarbital Side Effects

Applies to mephobarbital: oral tablet

Nervous system

Nervous system side effects including primarily somnolence (1% to 3%) have been reported. Agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, hallucination, insomnia, anxiety, dizziness, and abnormal thinking have all been reported to occur in less than 1% of treated patients. Headache has been reported with chronic use.[Ref]

Respiratory

Respiratory side effects including hypoventilation and apnea have been reported to occur in less than 1% of treated patients.[Ref]

Cardiovascular

Cardiovascular side effects including bradycardia, hypotension, and syncope have been reported to occur in less than 1% of treated patients.[Ref]

Gastrointestinal

Gastrointestinal side effects including nausea, vomiting, and constipation have been reported to occur in less than 1% of treated patients.[Ref]

Hypersensitivity

Hypersensitivity side effects including angioedema, skin rashes, and exfoliative dermatitis have been reported to occur with chronic use in less than 1% of treated patients.[Ref]

General

General side effects including fever have been reported to occur with chronic use in less than 1% of treated patients.[Ref]

Hepatic

Hepatic side effects including liver damage have been reported to occur with chronic use in less than 1% of treated patients.[Ref]

Hematologic

Hematologic side effects including megaloblastic anemia have been reported to occur with chronic use in less than 1% of treated patients.[Ref]

References

1. "Product Information. Mebaral (mephobarbital)" Sanofi Winthrop Pharmaceuticals, New York, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide